Cladribine Intravenous and Lithium Controlled-Release and Extended-Release Tablets
Determining the interaction of Cladribine Intravenous and Lithium Controlled-Release and Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cladribine
Brand name: Mavenclad, Leustatin
Synonyms: Cladribine
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cladribine Intravenous-Lithium ER
- Cladribine Intravenous-Lithium Oral Solution
- Cladribine Intravenous-Lithium Salts
- Cladribine Intravenous-Lithium Syrup and Oral Solution
- Cladribine Intravenous-Lithobid
- Cladribine Intravenous-Lithostat
- Lithium Controlled-Release and Extended-Release Tablets-Cladribine Tablets
- Lithium Controlled-Release and Extended-Release Tablets-Claforan
- Lithium Controlled-Release and Extended-Release Tablets-Claforan in D5W
- Lithium Controlled-Release and Extended-Release Tablets-Claravis
- Lithium Controlled-Release and Extended-Release Tablets-Clarifoam EF
- Lithium Controlled-Release and Extended-Release Tablets-Clarinex